Evaluation of two CE-IVD tests for BCR-ABL1 transcript monitoring of chronic myeloid leukemia patients

Leuk Lymphoma. 2021 May;62(5):1239-1242. doi: 10.1080/10428194.2020.1861274. Epub 2020 Dec 25.

Authors

Adam Folta¹, Tomas Jurcek¹, Blanka Kubesova¹, Daniela Zackova^{1

2}, Lukas Semerad^{1

2}, Jiri Mayer^{1

2

3}, Ivana Jeziskova^{1

2}

Affiliations

¹ Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
² Department of Internal Medicine - Hematology and Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
³ Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.

PMID: 33356699
DOI: 10.1080/10428194.2020.1861274

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Fusion Proteins, bcr-abl / genetics
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / diagnosis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / genetics
Leukemia, Myeloid*

Substances

Fusion Proteins, bcr-abl